Fatal familial insomnia

Fatal familial insomnia (FFI) is an extremely rare, inherited prion disease caused by a specific mutation (D178N) in the PRNP gene on chromosome 20, in combination with methionine at codon 129 on the mutant allele. It belongs to the group of transmissible spongiform encephalopathies and primarily affects the thalamus, a brain structure critical for regulating sleep, autonomic function, and endocrine activity. Progressive and selective neurodegeneration of the thalamus leads to the hallmark symptom of increasingly severe and ultimately untreatable insomnia. A sporadic form, known as sporadic fatal insomnia (sFI), occurs without the familial PRNP mutation but presents with a similar clinical picture. The disease typically manifests in mid-adulthood, most commonly between the ages of 40 and 60, though onset can range from the late 20s to the early 70s. Early symptoms include progressive insomnia, autonomic dysfunction (such as excessive sweating, elevated heart rate, hypertension, and irregular body temperature), and cognitive difficulties. As the disease advances, patients develop worsening sleep disturbances with dream-like hallucinatory states (oneirism), progressive dementia, weight loss, motor abnormalities including ataxia and myoclonus, and dysarthria. The autonomic nervous system, endocrine system, and central nervous system are all significantly affected. The clinical course is relentlessly progressive, with a median survival of approximately 18 months from symptom onset, though this can range from 7 to 36 months. Individuals homozygous for methionine at codon 129 tend to have a shorter disease duration compared to heterozygous individuals. There is currently no cure or disease-modifying treatment for fatal familial insomnia. Management is entirely supportive and palliative, focusing on symptom relief. Standard sleep medications are generally ineffective and may worsen the condition. Research into potential therapies, including anti-prion compounds, is ongoing but remains in early stages.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Fatal familial insomnia